| | ||||||||
| "anti diabetes" | ||||||||
| NEWS | ||||||||
Markets rise as hopes of Fed rate hike dims; Rate sensitives rally Lupin has risen by nearly 2% after it signed a marketing agreement with drug maker Boehringer Ingelheim to sell the latter's anti-diabetes drug ...
| ||||||||
| You have received this email because you have subscribed to Google Alerts. |
Receive this alert as RSS feed |
| Send Feedback |
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.